Peer-reviewedCC BYFrontiers in immunology
A NET-associated immunothrombotic phenotype is associated with coronary no-reflow and myocardial injury after primary PCI in ST-segment elevation myocardial infarction: a real-world translational cohort
- 1Department of Aortic Surgery, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University , ,
Related
- Microtubule-associated protein 1S (MAP1S): a cardioprotective factor against post-myocardial infarction remodeling via apoptosis inhibition
- Identification and validation of cholesterol homeostasis and NK cell-associated predictive and therapeutic models for Coronary atherosclerotic heart disease patients with ST-elevated myocardial infarction: Insights from artificial intelligence and multi-omics
- From marrow memory to adverse ventricular remodeling: trained immunity after myocardial infarction
- Poor survival after myocardial infarction in immune deficient NXG B2m mice is alleviated by transplantation of induced pluripotent stem cell derived cardiomyocytes (iPSC-CM) formulated as spheres, but not single cells
- Re. The influence of personality on the risk of myocardial infarction in UK Biobank cohort
BibTeX
@article{sun2026netassociated,
title = {{A NET-associated immunothrombotic phenotype is associated with coronary no-reflow and myocardial injury after primary PCI in ST-segment elevation myocardial infarction: a real-world translational cohort}},
author = {Zhigang Sun and Zhidong Zhang and Gang Qiao and Fangyuan Jia},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657948},
note = {CC BY},
}
RIS
TY - JOUR
TI - A NET-associated immunothrombotic phenotype is associated with coronary no-reflow and myocardial injury after primary PCI in ST-segment elevation myocardial infarction: a real-world translational cohort
AU - Zhigang Sun
AU - Zhidong Zhang
AU - Gang Qiao
AU - Fangyuan Jia
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13657948
SN - 1664-3224
ER -